A drug being tested for breast cancer might help to block the progression of myeloproliferative neoplasms, and possibly become a treatment for acute myeloid leukaemia, researchers have reported.
Scientists studied the impact of inhibiting the prot...
2 months ago
Immunotherapy based on natural killer (NK) cells is showing promise in early trials involving patients with lymphoma, researchers have reported.
The CAR-NK immunotherapy, called FT596, is easier to manufacture than CAR-T treatment, as it generated...
2 months ago
